Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: paclitaxel|GENETIC: fluorescence in situ hybridization|OTHER: immunohistochemistry staining method
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)